Search Articles

View query in Help articles search

Search Results (1 to 10 of 40 Results)

Download search results: CSV END BibTex RIS


Design and Baseline Evaluation of Social Media Vaping Prevention Trial: Randomized Controlled Trial Study

Design and Baseline Evaluation of Social Media Vaping Prevention Trial: Randomized Controlled Trial Study

The latest e-cigarettes also contain some of the highest nicotine levels ever seen in tobacco products [4-7]. The use of e-cigarettes has also been associated with worsened lung health and mental well-being [8-12]. In addition to e-cigarettes, other novel nicotine products are growing in popularity. Cornacchione Ross et al [13] found that approximately 17.1% of youth reported using flavored novel oral nicotine products (ONPs) in the past month. Common products included gum, gummies, and lozenges.

William Douglas Evans, Megumi Ichimiya, Jeffrey B Bingenheimer, Jennifer Cantrell, Alexander P D'Esterre, Olivia Pincus, Linda Q Yu, Elizabeth C Hair

J Med Internet Res 2025;27:e72002

Contextualizing Changes in e-Cigarette Use During the Early COVID-19 Pandemic and Accompanying Infodemic (“So Much Contradictory Evidence”): Qualitative Document Analysis of Reddit Forums

Contextualizing Changes in e-Cigarette Use During the Early COVID-19 Pandemic and Accompanying Infodemic (“So Much Contradictory Evidence”): Qualitative Document Analysis of Reddit Forums

Globally, the pandemic influenced multiple addictive behaviors, including alcohol consumption [11,12], gambling [13], cannabis use [14,15], and tobacco and nicotine use [12,16-20].

Shannon Lea Watkins, Katherine Snodgrass, Lexi Fahrion, Emily Shaw

J Med Internet Res 2025;27:e66010

Proximal Effects of a Just-in-Time Adaptive Intervention for Smoking Cessation With Wearable Sensors: Microrandomized Trial

Proximal Effects of a Just-in-Time Adaptive Intervention for Smoking Cessation With Wearable Sensors: Microrandomized Trial

Individuals who smoked and were treatment-seeking received the JITAI and brief counseling, which were implemented in the first 2 weeks, along with 6 weeks of nicotine replacement therapy (NRT). Mindfulness-based content delivered via the JITAI was the primary treatment element. Data for the proximal effects of the MRT was acquired via ecological momentary assessment (EMA).

Christine Vinci, Steve K Sutton, Min-Jeong Yang, Sarah R Jones, Santosh Kumar, David W Wetter

JMIR Mhealth Uhealth 2025;13:e55379

Large Language Models’ Accuracy in Emulating Human Experts’ Evaluation of Public Sentiments about Heated Tobacco Products on Social Media: Evaluation Study

Large Language Models’ Accuracy in Emulating Human Experts’ Evaluation of Public Sentiments about Heated Tobacco Products on Social Media: Evaluation Study

Heated tobacco products (HTPs) are emerging tobacco products that heat processed tobacco leaves, enabling users to breathe nicotine into their lungs [1]. As these products gain global market share at a rapid pace, their potential impacts on tobacco prevention and cessation initiatives are becoming an important topic of public debate [2].

Kwanho Kim, Soojong Kim

J Med Internet Res 2025;27:e63631

Utilization and Experiences of Using Quit Now, a Nicotine and Tobacco Smoking Cessation Website: Thematic Analysis

Utilization and Experiences of Using Quit Now, a Nicotine and Tobacco Smoking Cessation Website: Thematic Analysis

This achievement can be attributed in part to the British Columbia government’s initiatives, such as the British Columbia Smoking Cessation Program, including Quit Now, which supports residents in covering the costs of Nicotine Replacement Therapy (NRT) and smoking cessation prescription drugs and provides those attempting to quit a variety of nicotine products with access to community and expert coaches.

Tala Salaheddin, Ramona H Sharma, Marcela Fajardo, Cameron Panter, Lauren De Souza, Sheila Kanyevu Matano, Laura Struik

J Med Internet Res 2025;27:e55592

Tobacco Use, Risk Perceptions, and Characteristics of Adults Who Used a Heated Tobacco Product (IQOS) in the United States: Cross-Sectional Survey Study

Tobacco Use, Risk Perceptions, and Characteristics of Adults Who Used a Heated Tobacco Product (IQOS) in the United States: Cross-Sectional Survey Study

THS is a smoke-free tobacco product that heats specially designed tobacco sticks (commercialized as Heat Sticks by Philip Morris Products S.A.) to temperatures below the level of combustion and produces an aerosol with substantially reduced (ie, 90%-95% lower, on average) levels of harmful and potentially harmful constituents compared with cigarette smoke while delivering similar levels of nicotine [13-15].

Hui G Cheng, Brendan Noggle, Andrea R Vansickel, Edward G Largo, Pierpaolo Magnani

JMIR Form Res 2025;9:e57398

The Rutgers Omnibus Study: Protocol for Quarterly Web-Based Surveys to Promote Rapid Tobacco Research

The Rutgers Omnibus Study: Protocol for Quarterly Web-Based Surveys to Promote Rapid Tobacco Research

Whereas tobacco control efforts have historically focused on cigarette smoking, the marketplace has evolved to include numerous products such as electronic nicotine vaping devices and “tobacco-free” nicotine pouches. Today, the tobacco marketplace is in constant flux, with the emergence of new products, flavors, and packaging styles on a regular basis [1,2], and tobacco use patterns are changing in turn [3,4].

Michelle T Bover Manderski, William J Young, Ollie Ganz, Cristine D Delnevo

JMIR Res Protoc 2024;13:e58203

Understanding e-Cigarette Addictiveness: Triangulation of Focus Group and Netnographic Data

Understanding e-Cigarette Addictiveness: Triangulation of Focus Group and Netnographic Data

These e-cigarette users regularly use very high nicotine doses to feel a nicotine flash. They often mentioned having developed a tolerance for lower nicotine doses, as this example demonstrates: I started with 18 mg nicotine. That was not enough for me to get a flash, so I switched to 24 mg. I don’t want less nicotine. I have been vaping 24 mg in the last 3 years and I am happy with it. Another user reported: I vape 18 mg in the morning with my coffee and as a nicotine boost during the day (…).

Marike Andreas, Nadja Grundinger, Nadine Wolber, Daria Szafran, Tatiana Görig, Ute Mons, Valerie Lohner, Sabine Vollstädt-Klein, Sven Schneider

J Med Internet Res 2024;26:e57970

e-Cigarettes, Smoking Cessation, and Weight Change: Retrospective Secondary Analysis of the Evaluating the Efficacy of e-Cigarette Use for Smoking Cessation Trial

e-Cigarettes, Smoking Cessation, and Weight Change: Retrospective Secondary Analysis of the Evaluating the Efficacy of e-Cigarette Use for Smoking Cessation Trial

Participants were not prescribed a fixed daily dose and were instructed to use the e-cigarettes according to their personal needs and preferences (sessions and puffs varied according to habits and nicotine dependence). A schedule for nicotine tapering was not implemented, and participants were instructed to return both used and unused e-cigarettes cartridges at the end of the 12-week treatment period.

Lynnette Lyzwinski, Meichen Dong, Russell D Wolfinger, Kristian B Filion, Mark J Eisenberg

JMIR Public Health Surveill 2024;10:e58260

A Novel mHealth App for Smokers Living With HIV Who Are Ambivalent About Quitting Smoking: Formative Research and Randomized Feasibility Study

A Novel mHealth App for Smokers Living With HIV Who Are Ambivalent About Quitting Smoking: Formative Research and Randomized Feasibility Study

The US treatment guidelines recommend people who smoke and are living with HIV be offered evidence-based treatment following best practices for treating nicotine dependence, which combines advice to quit, skills-based training (via counseling or self-help materials), and pharmacotherapy (eg, nicotine replacement therapy [NRT], varenicline, and bupropion) [18,19].

Jennifer B McClure, Jaimee L Heffner, Chloe Krakauer, Sophia Mun, Sheryl L Catz

JMIR Form Res 2024;8:e58063